BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9382967)

  • 1. Urinary endothelin-like immunoreactivity in patients with cirrhosis.
    Saló J; Fernández-Esparrach G; Ginès P; Ginès A; Guevara M; Sort P; Jiménez W; Arroyo V; Rivera F; Rodés J
    J Hepatol; 1997 Nov; 27(5):810-6. PubMed ID: 9382967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
    Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
    Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.
    Trevisani F; Colantoni A; Gerbes AL; Gülberg V; Sica G; Caraceni P; De Notariis S; Morselli-Labate AM; Ligabue A; Gasbarrini G; Bernardi M
    J Hepatol; 1997 Apr; 26(4):808-15. PubMed ID: 9126793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of endothelin in cirrhosis.
    Asbert M; Ginès A; Ginès P; Jiménez W; Clària J; Saló J; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1993 May; 104(5):1485-91. PubMed ID: 8482460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining.
    Bernardi M; Trevisani F; Fornalè L; Di Marco C; Gasbarrini A; Baraldini M; Ligabue A; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):1116-22. PubMed ID: 7699237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems.
    Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL
    J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
    Pérez-Ayuso RM; Arroyo V; Camps J; Rimola A; Costa J; Gaya J; Rivera F; Rodés J
    Hepatology; 1984; 4(2):247-52. PubMed ID: 6368354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin levels in cirrhotic subjects.
    Veglio F; Pinna G; Melchio R; Rabbia F; Panarelli M; Gagliardi B; Chiandussi L
    J Hepatol; 1992 May; 15(1-2):85-7. PubMed ID: 1387139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity.
    Hoffman A; Grossman E; Goldstein DS; Gill JR; Keiser HR
    Kidney Int; 1994 Feb; 45(2):556-60. PubMed ID: 8164445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S; Bologna E; Terracina D; Angelico M
    Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
    Uchihara M; Izumi N; Sato C; Marumo F
    Hepatology; 1992 Jul; 16(1):95-9. PubMed ID: 1535610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?
    Trevisani F; Bernardi M; Gasbarrini A; Tamè MR; Giancane S; Andreone P; Baraldini M; Cursaro C; Ligabue A; Gasbarrini G
    J Hepatol; 1992 Sep; 16(1-2):190-6. PubMed ID: 1484152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
    Ginès A; Escorsell A; Ginès P; Saló J; Jiménez W; Inglada L; Navasa M; Clària J; Rimola A; Arroyo V
    Gastroenterology; 1993 Jul; 105(1):229-36. PubMed ID: 8514039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.